(UPDATED) Ischemia with no obstructive coronary arteries (INOCA) produces symptoms that affect physical functioning, mental health, and quality of life, a new survey of patients diagnosed with the ...

Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...

CHICAGO -- The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease. For symptomatic ...

CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring new frontiers for GLP-1 drugs in cardiovascular medicine, and foundational ...

Please provide your email address to receive an email when new articles are posted on . Six primary prevention risk assessment scores, including the Framingham risk score, Atherosclerotic ...

Please provide your email address to receive an email when new articles are posted on . Learning from women’s experiences may be key to improving INOCA diagnosis and care. Four themes that may improve ...

Machine-learning physiologic signal model achieved 90% sensitivity and 99% negative predictive value for ischemia detection in symptomatic patients The model showed strong sensitivity in both ...

MONTREAL, Canada—Intensive medical therapy (IMT) bests usual care for reducing noncalcified coronary plaque in women who have ischemia with nonobstructive coronary arteries (INOCA), according to ...

Ischemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that ...

MAKANDA — Kay Rippelmeyer-Tippy will present “An Illustrated Chronicle of the Inoca in Southern Illinois: From Glaciers to Genocide” at 1 to 2:30 p.m. Feb. 28. After a brief focus on the spectacular ...